Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infusional Gemcitabine + Carboplatin in NSCLC
NCT00212043Phase 2Completed
- Sponsor
- National University Hospital
- Start
- Jul 2000
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by National University Hospital. Started Jul 2000; status: completed.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00212043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212043.